11/21/2014
Nearly half the world's adult population will be overweight or obese by 2030, should present trends continue. | Read More
11/21/2014
A new investigation by the US Government Accountability Office has found that 5 Web sites operated by the CMS to help patients obtain healthcare cost and quality information fail to hit the mark. | Read More
11/21/2014
Individuals with asthma or COPD have an increased risk of IBD incidence. | Read More

WEEKLY TOP ARTICLES

11/21/2014

According to a study spanning 14 years, patients with type 1 diabetes are at a much higher risk of mortality.

continue reading
11/21/2014

A recent study found that using nivolumab as first-line therapy for metastatic melanoma showed significantly better outcomes when compared with chemotherapy.

continue reading
11/21/2014

The FDA granted breakthrough therapy designation to dupilumab for adults with moderate-to-severe atopic dermatitis.

continue reading
11/21/2014

Approximately 1 in 5 people with type 2 diabetes do not respond favorably to exercise.

continue reading
11/21/2014

Controversial heart disease prevention guidelines that abandoned specific targets for reducing LDL cholesterol are under fresh assault after a major study highlighted the benefits of taking LDL to very low levels.

continue reading
11/20/2014

or women with BRCA mutations who develop breast cancer, the risk of a cancer in the other breast may increase with time, a new analysis suggests.

continue reading

Healthcare Reform

Employees this year will contribute an average $4823 each toward health insurance premiums for family coverage.

View More

More than 7 in 10 Americans who bought health insurance through the exchanges earlier this year rated the quality of their healthcare and coverage as "excellent" or "good."

View More

Health officials proposed significantly expanding what researchers are required to report about clinical trials of drugs, devices, and other interventions.

View More

Medicare/Medicaid

A new investigation by the US Government Accountability Office has found that 5 Web sites operated by the CMS to help patients obtain healthcare cost and quality information fail to hit the mark.

View More

Medicaid spending rose the most of all states' budget areas, increasing 11.3% in fiscal 2014, but the federal government shouldered most of the burden.

View More

The CMS made a preliminary decision to cover lung cancer screening with low-dose computed tomography for eligible patients.

View More

Pharmaceutical News

A recent study found that using nivolumab as first-line therapy for metastatic melanoma showed significantly better outcomes when compared with chemotherapy.

View More

A class of drugs used for three decades by people infected with the virus that causes AIDS may be effective in treating a leading cause of blindness.

View More

Global drug spending will top $1 trillion in 2014, particularly due to novel treatments for hepatitis C and oncology drugs.

View More

FDA Activity

The FDA granted breakthrough therapy designation to dupilumab for adults with moderate-to-severe atopic dermatitis.

View More

The FDA approved once-daily long-acting hydrocodone bitartrate, a narcotic painkiller with abuse-resistant properties.

View More

The FDA approved bevacizumab for use in combination with chemotherapy for the treatment of women with platinum-resistant, recurrent ovarian cancer.

View More

Healthcare News

Less than one-third of older adults use the Internet to obtain health information.

View More

More breast cancer patients in the U.S. with early disease are opting for mastectomy instead of breast-conserving procedures that deliver equal results.

View More

The Joint Commission recently released its 2014 Annual Report, indicating an 11% increase in top-performing hospitals from 2013 to 2014.

View More

Guideline Updates

Controversial heart disease prevention guidelines that abandoned specific targets for reducing LDL cholesterol are under fresh assault after a major study highlighted the benefits of taking LDL to very low levels.

View More

During a very well attended session at the ACR meeting, a panel of speakers discussed the 2015 draft guidelines for rheumatoid arthritis treatment.

View More

Approximately 2.2 million platelet doses are transfused in the US each year, but platelet transfusion is not without risks.

View More
Once again, HCV is at the forefront of discussions as the FDA just recently approved the first once-daily oral combination of ledipasvir and sofosbuvir to treat HCV genotype 1 infection, which comes with an even larger pricetag: $94,500 for a 12-week course of treatment. continue reading
Boston—Multiple sclerosis (MS) is the most common chronic disease affecting the central nervous system in young adults, a continue reading